Search results
Results from the WOW.Com Content Network
Cryptococcus gattii, formerly known as Cryptococcus neoformans var. gattii, is an encapsulated yeast found primarily in tropical and subtropical climates. Its teleomorph is Filobasidiella bacillispora , a filamentous fungus belonging to the class Tremellomycetes .
[53] 19% of all AIDS-related deaths are due to cryptococcal disease. [54] Cryptococcal disease is the second leading cause of death in those with HIV/AIDS, second only to tuberculosis, which is responsible for 40% of deaths. [55] In sub-Saharan Africa approximately a third of HIV patients will develop cryptococcosis. [56]
To change this template's initial visibility, the |state= parameter may be used: {{Infectious disease symptoms and signs | state = collapsed}} will show the template collapsed, i.e. hidden apart from its title bar. {{Infectious disease symptoms and signs | state = expanded}} will show the template expanded, i.e. fully visible.
Cryptococcus (Cryptococcal meningitis) - it is thought to be acquired through inhalation of soil contaminated with bird droppings. C. neoformans is the most common pathogen to cause fungal meningitis. Aspergillus - Aspergillus infections account for 5% of fungal infections involving the central nervous system.
Cryptococcus neoformans is an encapsulated basidiomycetous yeast [1] belonging to the class Tremellomycetes and an obligate aerobe [2] that can live in both plants and animals. Its teleomorph is a filamentous fungus , formerly referred to Filobasidiella neoformans .
Cryptosporidiosis, sometimes informally called crypto, [1] is a parasitic disease caused by Cryptosporidium, a genus of protozoan parasites in the phylum Apicomplexa.It affects the distal small intestine and can affect the respiratory tract in both immunocompetent (i.e., individuals with a normal functioning immune system) and immunocompromised (e.g., persons with HIV/AIDS or autoimmune ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate
WHO Disease Staging System for HIV Infection and Disease was first produced in 1990 by the World Health Organization [1] and updated in 2007. [2] It is an approach for use in resource limited settings and is widely used in Africa and Asia and has been a useful research tool in studies of progression to symptomatic HIV disease .